Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Histidine Tag (His-Tag) Antibody Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for antibodies targeting histidine-tagged proteins has seen substantial expansion lately. Estimates project a rise from $1.43 billion in 2025 to $1.6 billion in 2026, reflecting a compound annual growth rate of 11.8%. Key factors fueling this growth during the past period include the proliferation of recombinant protein investigations, the increasing number of academic laboratories focused on life sciences, a greater adoption of affinity purification methods, the establishment of reliable tagging protocols, and augmented financial support for molecular biology studies.

The market for histidine-tag (his-tag) antibodies is poised for substantial expansion in the coming years, projecting a market value of $2.48 billion by 2030, with a compound annual growth rate (CAGR) standing at 11.5%. This anticipated growth is driven by a confluence of factors, including a heightened need for sophisticated protein analysis instruments, advancements in biopharmaceutical research endeavors, a broader acceptance of recombinant and nanobody structures, a greater emphasis on the precision and reliability of assays, and the increasing integration of automated processes within laboratory operations. Key developments anticipated during this forecast period involve a surge in the requirement for research antibodies possessing high specificity, a more prevalent utilization of his-tag antibodies for protein purification processes, a growing trend towards adopting recombinant antibody formats, an amplification of studies involving the expression of tagged proteins, and a heightened dedication to ensuring the reproducibility of findings in life sciences research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30296&type=smp

Histidine Tag (His-Tag) Antibody Market Demand Drivers Creating New Revenue Opportunities

The expanding need for biopharmaceutical products, which are manufactured through biological means or advanced biotechnological processes instead of conventional chemical methods, is poised to be a significant catalyst for the expansion of the histidine tag (His-Tag) antibody market. This heightened demand for biopharmaceuticals stems from the escalating incidence of chronic and intricate health conditions, necessitating sophisticated, targeted treatments that traditional medications struggle to address effectively. Histidine tag (His-Tag) antibodies play a crucial role in biopharmaceutical research by facilitating accurate identification and isolation of recombinant proteins, thereby becoming indispensable tools in the advancement of new drugs and the production of therapeutic proteins. Their inherent high specificity and consistent outcomes contribute to a reduction in experimental inaccuracies, thereby enhancing the effectiveness of research endeavors and the dependability of bioprocesses. Illustratively, the Centers for Medicare & Medicaid Services (CMS), a U.S. federal body, reported in June 2025 that expenditures on prescription drugs surged by 11.4% in 2023, reaching $449.7 billion, a notable acceleration from the 7.8% increase observed in 2022. Consequently, the escalating requirement for biopharmaceuticals is directly fueling the growth trajectory of the histidine tag (His-Tag) antibody market.

Histidine Tag (His-Tag) Antibody Market Segment Analysis Highlighting Growth Areas

The histidine tag (his-tag) antibody market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Nanobodies, Other Product Types

2) By Application: Western Blotting, Immunoprecipitation, Flow Cytometry, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Mouse Monoclonal, Rabbit Monoclonal, Rat Monoclonal, Humanized Monoclonal, Chimeric Monoclonal, Isotype Control Monoclonal

2) By Polyclonal Antibodies: Rabbit Polyclonal, Goat Polyclonal, Chicken Polyclonal, Donkey Polyclonal, Sheep Polyclonal, Serum Free Polyclonal

3) By Recombinant Antibodies: Recombinant Rabbit Monoclonal, Recombinant Mouse Monoclonal, Single Chain Variable Fragment, Fragment Antigen Binding, Multispecific Engineered Antibody, Recombinant Antibody Pair Capture And Detection

4) By Nanobodies: Single Domain Antibody Camelid, Single Domain Antibody Alpaca, Fluorescent Protein Fused Nanobody, Enzyme Conjugated Nanobody, Immobilized Nanobody For Affinity Purification, Intrabody Nanobody For Intracellular Detection

5) By Other Product Types: Secondary Antibodies Against Histidine Tag, Conjugated Secondary Antibodies Against Histidine Tag, Magnetic Beads Nickel Nitrilotriacetic Acid, Agarose Beads Nickel Nitrilotriacetic Acid, Enzyme Linked Immunosorbent Assay Kits For Histidine Tag, Lateral Flow Assays For Histidine Tag

Histidine Tag (His-Tag) Antibody Market Trends Driving Strategic Industry Expansion

Key players within the histidine tag (His-Tag) antibody market are making strides in creating cutting-edge solutions, exemplified by the development of automated biosensor-based kits designed for the quantification of His-tagged proteins. These kits aim to expedite and unify the process of detecting proteins, whether they are in their raw or purified state. The introduction of automated biosensor-based His-Tag quantification kits signifies commercially available assay kits employing biosensor technology to automatically identify and quantify His-tagged proteins. A notable example occurred in November 2025 when HexagonFab Limited, operating under the name Abselion, a UK-based entity specializing in life science tools, unveiled its Tagged Protein Quantification Kit for His-tag and its corresponding His-tag Quantification sensor. This innovative system, integrated with the Amperia platform and developed in conjunction with GenScript’s THE His Tag monoclonal antibodies, offers a swift, ready-to-use, and antibody-independent approach to measuring His-tagged proteins directly within crude sample matrices. When utilized in conjunction with Abselion’s Amperia biosensors, this integrated system facilitates real-time, label-free analysis, thereby simplifying the protein characterization process by eliminating the necessity for diverse, standalone instruments. Its primary objective is to hasten expression screening, refine bioprocess optimization, and enhance quality control through the provision of reliable His-tagged protein measurements, accessible even to personnel without specialized training.

Histidine Tag (His-Tag) Antibody Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the histidine tag (his-tag) antibody market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories Inc., GeneTex Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Sino Biological Inc., Cell Signaling Technology Inc., Wuhan Elabscience Biotechnology Co. Ltd., ABclonal Technology Co. Ltd., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Diagnostics Inc., Aviva Systems Biology Corporation, Abnova Corporation, Boster Biological Technology Co. Ltd., Columbia Biosciences Corporation, NSJ Bioreagents

Access The Complete Histidine Tag (His-Tag) Antibody Market Report:

https://www.thebusinessresearchcompany.com/report/global-histidine-tag-his-tag-antibody-market-report

Histidine Tag (His-Tag) Antibody Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the histidine tag (His-Tag) antibody market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the histidine tag (his-tag) antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model